Blog
Is Facebook Stock a Buy?
Facebook (NASDAQ: FB) stock price continues its march higher. It is currently trading near all-time highs as a substantial percentage of the world's population uses its platforms every month
Consider This Before You Buy Lemonade
Archegos Capital Management's recent meltdown shines a light on a fact of life that financial companies don't like to talk about: counterparty risk. Briefly, Archegos was a hedge fund that used
Is LendingClub a Buy?
When it launched in 2006, LendingClub (NYSE: LC) was a pioneer in peer-to-peer lending, offering a digital marketplace for individuals and businesses to obtain loans from one another instead of
Got $5,000? These 2 Ultra-Cheap Stocks Are Bargain Buys
If you have money to invest and want to make the most of it, you should consider putting it into cheap stocks that can easily rise in value. This is a wiser approach than investing in an expensive
1 Big-Cap Fintech Many Investors Haven't Heard of
When it comes to big-cap fintech, stocks like PayPal (NASDAQ: PYPL) and Square generally come to mind for most investors. But there's another big player called Adyen (OTC: ADYE.Y) that should be on
These 3 Value Stocks Are Absurdly Cheap Right Now
Spring is in the air, baseball season is underway, and long overdue summer vacations are just around the corner. Things are looking up in the real world, and the U.S. stock market reached a new
Microsoft's $20 Billion Bet on Nuance
Microsoft (NASDAQ: MSFT) has been on a yearslong shopping spree, including recent rumors that it is interested in buying gaming chat start-up Discord for over $10 billion. The enterprise software
3 Beaten-Down Biotech Stocks: Can They Recover?
The past month has been awfully hard on biotech stocks across the board. That made it an inauspicious time to report clinical trial results that were anything less than outstanding.
Apparently
Is Disney Stock a Buy?
The last year has been transformational for Walt Disney (NYSE: DIS). There aren't many diversified businesses that were impacted in so many ways by the pandemic. But the company navigated the
Only 25% of Americans Know This Important Retirement Savings Rule
Social Security won't provide enough income for you to live comfortably during retirement. Rather, you'll need savings of your own to supplement those benefits and ensure that you can cover all of
Forget Aphria and Tilray: This Cannabis Merger Is Much More Promising
There has been a significant uptick in mergers and acquisitions (M&A) activity in the burgeoning cannabis industry lately. This month, Canopy Growth announced plans to acquire Supreme Cannabis. And
Is Quantum Computing Startup IonQ a Buy Ahead of Its SPAC Merger?
Special purpose acquisition company (SPAC) dMY Technology Group III (NYSE: DMYI) recently announced that it will be merging with quantum computing start-up IonQ. A number of quantum computing deals
4 Income Stocks You Can Add to Your Portfolio Today
It's understandable why so many investors love dividend stocks. Even if you're not an income investor, the ability to generate some extra passive income from your portfolio is appealing. And
4 Behaviors That Could Make You a Millionaire
Maybe you want to save up $1 million but don't know how to do it. While many people want to achieve this milestone, only about 7.6% of Americans do.
Becoming a millionaire is possible, but will
These 6 Words From Moderna's CMO May Mean Billions in 2022
Moderna (NASDAQ: MRNA) is already on its way to billion-dollar revenue this year. The company in February said advance purchase agreements for its coronavirus vaccine translate into $18.4 billion in
3 Top Cannabis Stocks to Buy in April
The volatility of the marijuana sector often overshadows the long-term returns the industry could deliver when it reaches its full potential. Because marijuana remains illegal at the federal level
1 Company Following Warren Buffett's Rules to Be the Next Berkshire Hathaway
In his most recent letter to Berkshire Hathaway (NYSE: BRK.A)(NYSE: BRK.B) shareholders, Warren Buffett spelled out some of the biggest reasons many conglomerates have been bad investments over the
Is Teladoc Health Stock a Buy?
Teladoc Health (NYSE: TDOC) was one of the best-performing healthcare stocks of the past five years, especially thanks to its performance in the last 18 months. If you'd invested just $10,000 into
Will HEXO's "Bake Sale" Ruin Its Chances of Posting a Profit?
In the second quarter of 2020, spending on the legal pot market in Canada finally came in ahead of the black market. One of the big reasons the industry has been making progress is that companies
This Important Acquisition Is Starting to Pay Off for Stryker
Stryker (NYSE: SYK) acquired Mako Surgical in 2013. It did so with a plan to combine the company's leadership with Mako's innovative robotic arm assisted surgical products in an effort to transform
3 High-Yield Dividend Stocks That'll Help You Crush Inflation
After more than a year, arguably the stock market's most persistent concern has returned: inflation.
Inflation describes the rising price of goods and services over time. A healthy economy is always
A Surprising Vaccine Rival May Upset the Dreams of Anyone Holding Moderna and Pfizer Stock
A small team of 10 researchers began designing vaccine candidates shortly after the genetic sequence of the SARS-CoV-2 virus was made public last January. For the past decade, the team had worked on
Here's the Biggest Challenge Pfizer Faces Right Now
It's fair to say Pfizer (NYSE: PFE) has become a coronavirus vaccine powerhouse. The big pharma company landed the first Emergency Use Authorization (EUA) for a COVID-19 vaccine in December. And it
Will Worse Side Effects for Moderna's Vaccine Boost Pfizer's Fortunes?
Three COVID-19 vaccines are currently available to Americans. One of them, however, faces some challenges. Johnson & Johnson won't be able to supply as many doses of its vaccine in the next few
5 Value Stocks With 26% to 50% Upside, According to Wall Street
For more than a decade, everything on Wall Street has revolved around growth stocks. Historically low lending rates and the previous 11-year economic expansion gave fast-paced companies a free pass


